Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00280878
Status:
COMPLETED
Last Update Posted:
2016-01-15
First Post:
2006-01-22
Brief Title:
Rituximab in Combination With Outpatient Therapy for CD20 Lymphoma
Sponsor:
Bayside Health
Organization:
Bayside Health
Organization Data
Organization:
Bayside Health
Class:
OTHER_GOV
Study ID:
AH20405
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bayside Health
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None